Targeting the SIRT3/mito-COX-2/p-Drp1Ser616 signaling axis promoted MQC-dependent chemosensitivity via multi-pattern, anti-tumor mechanisms in HCC. The gene discussed is PTGS2; the disease is hepatocellular carcinoma.